REFERENCES
- Abraham I., Goundalkar A., Mezei M. Effect of liposomal surface charge on the pharmacokinetics of an encapsulated model compound. Biopharm. Drug Dispos. 1984; 5: 387–398, [PUBMED], [INFOTRIEVE], [CSA]
- Akhtar S., Kole R., Juliano R. L. Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci. 1991; 49: 169–174, [CSA], [CROSSREF]
- Aoki H., Tottori T., Sakurai F., Fuji K., Miyajima K. Effects of positive charge density on the liposomal surface on disposition kinetics of liposomes in rats. Int. J. Pharm. 1997; 156: 163–174, [CSA], [CROSSREF]
- Blum H. E., Galun E., Weizsacker F., Wands J. R. Inhibition of hepatitis B virus by antisense oligodeoxynucleotides. Lancet 1991; 337: 1230, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Crooke S. T., Graham M. J., Zuckerman J. E., Brooks D., Conklin B. S., Cummins L. L., Greig M. J., Guinosso C. J., Kornbrust D., Manoharan M., Sasmor H. M., Schleich T., Tivel K. L., Griffey R. H. Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J. Pharmacol. Exp. Ther. 1996; 277: 923–937, [PUBMED], [INFOTRIEVE], [CSA]
- Dusheiko G. M. Treatment and prevention of chronic viral hepatitis. Pharmacol. Therapeut. 1995; 65: 47–73, [CSA], [CROSSREF]
- Gao X., Hang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 1991; 179: 280–285, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hope M. J., Mui B., Ansell S., Ahkong Q. F. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs. Mol. Membr. Biol. 1998; 15: 1–14, [PUBMED], [INFOTRIEVE], [CSA]
- Koike K., Hara T., Aramak Y., Takada S., Tsuchiya S. Receptor-mediated gene transfer into hepatic cells using asialoglycoprotein-labeled liposomes. Ann. NY Acad. Sci. 1994; 716: 331–333, [PUBMED], [INFOTRIEVE], [CSA]
- Kuhl T., Guo Y., Alderfer J. L., Berman A. D., Leckband D., Israelachvili J., Hui S. W. Direct measurement of polyethylene glycol induced depletion attraction between lipid bilayers. Langmuir 1996; 12: 3003–3014, [CSA], [CROSSREF]
- Litzinger D. C., Brown J. M., Wala I., Kaufman S. A., Van G. Y., Farrell C. L., Collins D. Fate of cationic liposomes and their complex with oligonucleotide in vivo. Biochim. Biophys. Acta 1996; 1281: 139–149, [PUBMED], [INFOTRIEVE], [CSA]
- Meyer O., Kirpotin D., Hong K., Sternberg B., Park J. W., Woodle M. C., Papahadjopoulos D. Cationic liposomes coated with polyethlene glycol as carriers for oligonucleotides. J. Biol. Chem. 1998; 273: 15621–15627, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Offensperger W. B., Offensperger S., Walter E., Teubner K., Lgloi G., Blum H. E., Gerok W. In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO J. 1993; 12: 1257–1262, [PUBMED], [INFOTRIEVE], [CSA]
- Remy J. S., Kichler A., Mordvinov V., Schuber F., Behr J. P. Targeted gene transfer into hepatoma cells with lipopolyaminecondensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc. Natl. Acad Sci. USA 1995; 92: 1744–1748, [PUBMED], [INFOTRIEVE], [CSA]
- Soni P. N., Brown D., Saffie R., Savage K., Moore D., Gregoriadis G., Dusheiko G. M. Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection. Hepatology 1998; 28: 1402–1410, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shimizu K., Maitani Y., Takahashi N., Takayama K., Nagai T. Association of liposomes containing a soybean-derived sterylglucoside mixture with rat primary cultured hepatocytes. Biol. Pharm. Bull. 1998; 21: 818–822, [PUBMED], [INFOTRIEVE], [CSA]
- Shimizu K., Maitani Y., Takayama K., Nagai T. Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting. Biol. Pharm. Bull. 1997; 29: 81–886, [CSA]
- Stuart D. D., Allen T. M. A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochim. Biophys. Acta 2000; 1463: 219–229, [PUBMED], [INFOTRIEVE], [CSA]
- Takehara T., Hayashi N., Miyamoto Y., Yamamoto M., Mita E., Fusamoto H., Kamada T. Expression of the hepatitis C virus genome in rat liver after cationic liposome-mediated in vivo gene transfer. Hepatology. 1995; 21: 746–751, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wagner R. W. Gene inhibition using antisense oligodeoxynucleotides. Nature 1994; 372: 333–335, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Woodle M. C., Collins L. R., Sponsler E., Kossovsky N., Papahaduopoulos D., Martin F. J. Sterically stabilized liposomes: reduction in electrophoretic mobility but not electrostatic surface potential. Biohpys. J. 1992; 61: 902–910, [CSA]
- Wu G. Y., Wu C. H. Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. J. Biol. Chem. 1992; 267: 12436–12439, [PUBMED], [INFOTRIEVE], [CSA]
- Zalipsky S., Brandeis E., Newman M. S., Woodle M. C. Long circulating, cationic liposomes containing amino-PEG-phosphatiylethanolamine. FEBS Lett. 1994; 353: 71–74, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zelphati O., Szoka F. C., Jr. Intracellular distribution and mechanism of delivery of oligomucleotides mediated by cationic lipid. Pharm. Res. 1996; 13: 1367–1372, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zelphati O., Uyechi L. S., Barron L. G., Szoka F. C., Jr. Effect of serum components on the physicochemical properties of cationic lipid/oligonucleotide complexes and on their interaction with cells. Biochim. Biophys. Acta 1998; 1390: 119–133, [PUBMED], [INFOTRIEVE], [CSA]